fluoxetine has been researched along with 7-nitroindazole in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, MS; Kim, CJ; Kim, KW; Park, EY; Park, JW; Shin, BS; Shin, MS; Woo, RS; Zhao, RJ | 1 |
| Burns, MP; Connor, TJ; Harkin, A; Kelly, JP | 1 |
| Hu, Y; Huang, XY; Luo, CX; Wu, DL; Wu, HY; Ye, ML; Zhang, J; Zhou, QG; Zhu, DY; Zhu, LJ | 1 |
| Chhillar, R; Dhingra, D | 1 |
| Almeida, J; Crestani, CC; Duarte, JO; Oliveira, LA | 1 |
| Corrêa da Silva, JA; da Silva, LM; de Souza, MM; Holzmann, I; Steimbach, VM | 1 |
| Bonassoli, VT; da Silva Leal, VM; de Oliveira, RMW; Milani, H; Soares, LM | 1 |
| Chamanara, M; Dehpour, AR; Nikoui, V; Norouzi-Javidan, A; Ostadhadi, S; Shakiba, S; Zolfaghari, S | 1 |
| Dehpour, AR; Hemmati, S; Mohammadi, S; Sadeghi, MA; Vafaei, A; Yousefi-Manesh, H; Zare, M | 1 |
| Chamanara, M; Dehpour, AR; Fekrvand, S; Foroutani, L; Hemmati, S; Hosseini, Y; Nassireslami, E; Sadeghi, MA; Yousefi Zoshk, M; Yousefi-Manesh, H | 1 |
10 other study(ies) available for fluoxetine and 7-nitroindazole
| Article | Year |
|---|---|
Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.
Topics: Adolescent; Adult; Arginine; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluoxetine; Ganglionic Stimulants; Guanylate Cyclase; Humans; In Vitro Techniques; Indazoles; Male; Mecamylamine; Methylene Blue; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nicotine; Nicotinic Antagonists; Nitrendipine; Nitric Oxide Synthase; Norepinephrine; omega-Conotoxin GVIA; Oxadiazoles; Purinones; Quinoxalines; Tetrodotoxin; Tritium; Tubocurarine | 2002 |
Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Escape Reaction; Fluoxetine; Imipramine; Immobilization; Indazoles; Male; Mice; Motor Activity; Nitric Oxide Synthase; Nitroarginine; Selective Serotonin Reuptake Inhibitors; Swimming | 2004 |
Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Animals, Newborn; Anxiety Disorders; CREB-Binding Protein; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Feeding Behavior; Fluoxetine; Gene Expression Regulation, Enzymologic; Hippocampus; Indazoles; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type I; Phosphorylation; Piperazines; Reaction Time; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2010 |
Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice.
Topics: Animals; Antidepressive Agents; Ellagic Acid; Emotions; Fenclonine; Fluoxetine; Guanidines; Hindlimb Suspension; Immobilization; Indazoles; Male; Mice; Motor Activity; Nitrites; Prazosin; Restraint, Physical; Stress, Psychological; Sulpiride; Swimming | 2012 |
Effects of nitric oxide synthesis inhibitor or fluoxetine treatment on depression-like state and cardiovascular changes induced by chronic variable stress in rats.
Topics: Animals; Antidepressive Agents; Autonomic Nervous System; Baroreflex; Behavior, Animal; Cardiovascular System; Chronic Disease; Corticosterone; Depression; Enzyme Inhibitors; Fluoxetine; Indazoles; Male; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Stress, Psychological; Swimming; Vasoconstrictor Agents; Vasodilator Agents; Weight Gain | 2015 |
Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.
Topics: Animals; Antidepressive Agents; Antioxidants; Arginine; Behavior, Animal; Disease Models, Animal; Drug Synergism; Fluoxetine; Hippocampus; Indazoles; Male; Methylene Blue; Mice; N-Methylaspartate; Olfactory Bulb; Oxidative Stress; Quercetin; Signal Transduction; Sildenafil Citrate | 2015 |
Depletion of 5 hydroxy-triptamine (5-HT) affects the antidepressant-like effect of neuronal nitric oxide synthase inhibitor in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Drug Tolerance; Fluoxetine; Hippocampus; Imines; Indazoles; Injections, Intraperitoneal; Male; Mice; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Serotonin | 2017 |
The role of nitric oxide-cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test.
Topics: Animals; Antidepressive Agents; Arginine; Cyclic GMP; Drug Synergism; Fluoxetine; Guanidines; Hippocampus; Immobility Response, Tonic; Indazoles; Male; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Prefrontal Cortex; Selegiline; Signal Transduction; Sildenafil Citrate; Swimming | 2018 |
Chronically altered NMDAR signaling in epilepsy mediates comorbid depression.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Depression; Epilepsy; Fluoxetine; Indazoles; Male; Oxidative Stress; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2021 |
Neuronal nitric oxide synthase inhibition accelerated the removal of fluoxetine's anxiogenic activity in an animal model of PTSD.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Fluoxetine; Hippocampus; Nitric Oxide; Nitric Oxide Synthase Type I; Rats; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic | 2023 |